PL3133396T3 - Sposób leczenia z zastosowaniem leków wychwytujących amoniak - Google Patents
Sposób leczenia z zastosowaniem leków wychwytujących amoniakInfo
- Publication number
- PL3133396T3 PL3133396T3 PL16176456T PL16176456T PL3133396T3 PL 3133396 T3 PL3133396 T3 PL 3133396T3 PL 16176456 T PL16176456 T PL 16176456T PL 16176456 T PL16176456 T PL 16176456T PL 3133396 T3 PL3133396 T3 PL 3133396T3
- Authority
- PL
- Poland
- Prior art keywords
- drugs
- ammonia
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6806—Determination of free amino acids
- G01N33/6812—Assays for specific amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/08—Hepato-biliairy disorders other than hepatitis
- G01N2800/085—Liver diseases, e.g. portal hypertension, fibrosis, cirrhosis, bilirubin
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/34—Genitourinary disorders
- G01N2800/347—Renal failures; Glomerular diseases; Tubulointerstitial diseases, e.g. nephritic syndrome, glomerulonephritis; Renovascular diseases, e.g. renal artery occlusion, nephropathy
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Physics & Mathematics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Bioinformatics & Computational Biology (AREA)
- Biophysics (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Emergency Medicine (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US4883008P | 2008-04-29 | 2008-04-29 | |
| US9323408P | 2008-08-29 | 2008-08-29 | |
| EP16176456.8A EP3133396B1 (en) | 2008-04-29 | 2009-01-07 | Methods of treatment using ammonia-scavenging drugs |
| PCT/US2009/030362 WO2009134460A1 (en) | 2008-04-29 | 2009-01-07 | Methods of treatment using ammonia-scavenging drugs |
| EP09739263.3A EP2330892B1 (en) | 2008-04-29 | 2009-01-07 | Methods of treatment using ammonia-scavenging drugs |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3133396T3 true PL3133396T3 (pl) | 2019-03-29 |
Family
ID=41255339
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL16176456T PL3133396T3 (pl) | 2008-04-29 | 2009-01-07 | Sposób leczenia z zastosowaniem leków wychwytujących amoniak |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US8642012B2 (pl) |
| EP (2) | EP3133396B1 (pl) |
| CA (1) | CA2735218A1 (pl) |
| CY (3) | CY1118543T1 (pl) |
| DK (1) | DK2330892T3 (pl) |
| GB (1) | GB2470310A (pl) |
| HU (1) | HUS1600057I1 (pl) |
| LT (1) | LTC2330892I2 (pl) |
| NL (1) | NL300854I2 (pl) |
| NO (1) | NO2016023I2 (pl) |
| PL (1) | PL3133396T3 (pl) |
| WO (1) | WO2009134460A1 (pl) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL3133396T3 (pl) | 2008-04-29 | 2019-03-29 | Horizon Therapeutics, Llc | Sposób leczenia z zastosowaniem leków wychwytujących amoniak |
| EP2954780A1 (en) | 2009-07-24 | 2015-12-16 | Baylor College Of Medicine | Methods of modulation of branched chain acids and uses thereof |
| DK2760479T3 (en) | 2011-09-30 | 2017-07-17 | Horizon Therapeutics Llc | Nitrogen-removing drug for use in a method of treating a nitrogen retention disorder |
| ES2623470T3 (es) | 2012-04-20 | 2017-07-11 | Horizon Therapeutics, Llc | HPN-100 para uso en el tratamiento de trastornos de retención de nitrógeno |
| EP2922576B1 (en) * | 2012-11-21 | 2017-11-08 | Horizon Therapeutics, LLC | Methods of administering and evaluating nitrogen scavenging drugs for the treatment of hepatic encephalopathy |
| EP2986325B1 (en) | 2013-10-14 | 2019-06-26 | Immedica Pharma AB | Methods of treating urea cycle disorders |
| TWI640327B (zh) | 2013-11-14 | 2018-11-11 | 美商奧崔基尼克斯製藥公司 | 三酸甘油酯之固體組合物及其用途 |
| CA2946422C (en) | 2014-04-30 | 2019-03-05 | The Johns Hopkins University | Dendrimer compositions and their use in treatment of diseases of the eye |
| US20170087113A1 (en) * | 2014-06-04 | 2017-03-30 | Horizon Therapeutics, Llc | Methods for treating urea cycle disorders to prevent hyperammonemic crises by controlling blood ammonia levels |
| CA2957721C (en) | 2014-08-13 | 2021-04-13 | The Johns Hopkins University | Selective dendrimer delivery to brain tumors |
| CA3003589C (en) | 2015-10-29 | 2021-12-07 | The Johns Hopkins University | Dendrimer compositions and methods for treatment of peroxisomal disorders and leukodystrophies |
| US9914692B2 (en) | 2016-05-25 | 2018-03-13 | Horizon Therapeutics, Llc | Procedure for the preparation of 4-phenyl butyrate and uses thereof |
| WO2018170234A1 (en) | 2017-03-15 | 2018-09-20 | President And Fellows Of Harvard College | Methods and compositions for treating cancer |
| IL270817B2 (en) * | 2017-05-24 | 2025-10-01 | Thoeris Gmbh | Use of glutamine synthetase to treat hyperammonemia |
| CA3068414A1 (en) | 2017-06-28 | 2019-01-03 | Baylor College Of Medicine | Combination therapy to treat urea cycle disorders |
| US10668040B2 (en) | 2017-09-11 | 2020-06-02 | Horizon Therapeutics, Llc | Treatment of urea cycle disorders in neonates and infants |
| WO2020198454A1 (en) | 2019-03-28 | 2020-10-01 | Zoll Medical Corporation | Systems and methods for providing drug prescription information with monitored cardiac information |
| JP7759322B2 (ja) | 2019-12-04 | 2025-10-23 | アシュバッタ セラピューティクス， インコーポレイテッド | 眼に薬物送達するためのデンドリマー組成物および方法 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4284647A (en) * | 1980-03-31 | 1981-08-18 | The Johns Hopkins University | Process for waste nitrogen removal |
| ES2157422T3 (es) * | 1995-02-07 | 2001-08-16 | Brusilow Entpr Llc | Trigliceridos y esteres etilicos de acido fenilalcanoico y acido fenilalquenoico utiles en el tratamiento de diversos trastornos. |
| DE19805854C1 (de) * | 1998-02-13 | 1999-05-12 | Claas Usines France | Schalteinrichtung für Schneidmesser |
| US6219567B1 (en) * | 1999-06-21 | 2001-04-17 | Cardiox Corporation | Monitoring of total ammoniacal concentration in blood |
| US20040229948A1 (en) | 2002-04-12 | 2004-11-18 | Summar Marshall L. | Method for preventing hepatic encephalopathic episodes |
| SG158073A1 (en) * | 2004-11-26 | 2010-01-29 | Ucl Business Plc | Compositions comprising ornithine and phenylacetate or phenylbutyrate for treating hepatic encephalopathy |
| US20060135612A1 (en) * | 2004-12-17 | 2006-06-22 | U.S. Department Of Veterans Affairs | Method of ameliorating or abrogating the effects of a neurodegenerative disorder, such as amyotrophic lateral sclerosis (ALS), by using a HDAC inhibiting agent |
| CN101959429B (zh) | 2008-01-08 | 2014-09-10 | 阿克塞利亚制药公司 | 抗微生物肽系统的激动剂 |
| PL3133396T3 (pl) | 2008-04-29 | 2019-03-29 | Horizon Therapeutics, Llc | Sposób leczenia z zastosowaniem leków wychwytujących amoniak |
| US20120022157A1 (en) | 2008-08-29 | 2012-01-26 | Ucyclyd Pharma, Inc | Dosing and monitoring patients on nitrogen-scavenging drugs |
-
2009
- 2009-01-07 PL PL16176456T patent/PL3133396T3/pl unknown
- 2009-01-07 CA CA2735218A patent/CA2735218A1/en not_active Withdrawn
- 2009-01-07 EP EP16176456.8A patent/EP3133396B1/en active Active
- 2009-01-07 EP EP09739263.3A patent/EP2330892B1/en active Active
- 2009-01-07 WO PCT/US2009/030362 patent/WO2009134460A1/en not_active Ceased
- 2009-01-07 US US12/350,111 patent/US8642012B2/en active Active
- 2009-01-07 DK DK09739263.3T patent/DK2330892T3/en active
- 2009-08-27 GB GB1013468A patent/GB2470310A/en not_active Withdrawn
-
2013
- 2013-12-19 US US14/135,318 patent/US20140256807A1/en not_active Abandoned
-
2016
- 2016-09-28 CY CY20161100962T patent/CY1118543T1/el unknown
- 2016-12-14 NO NO2016023C patent/NO2016023I2/no unknown
- 2016-12-15 HU HUS1600057C patent/HUS1600057I1/hu unknown
- 2016-12-16 LT LTPA2016041C patent/LTC2330892I2/lt unknown
- 2016-12-21 NL NL300854C patent/NL300854I2/nl unknown
- 2016-12-22 CY CY2016053C patent/CY2016053I1/el unknown
-
2018
- 2018-11-21 CY CY20181101231T patent/CY1121288T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US8642012B2 (en) | 2014-02-04 |
| EP2330892A4 (en) | 2012-01-11 |
| NO2016023I2 (no) | 2016-12-27 |
| NL300854I2 (pl) | 2017-02-02 |
| EP3133396A1 (en) | 2017-02-22 |
| CY2016053I2 (el) | 2017-06-28 |
| NO2016023I1 (no) | 2016-12-14 |
| WO2009134460A1 (en) | 2009-11-05 |
| EP3133396B1 (en) | 2018-09-05 |
| CY1121288T1 (el) | 2020-05-29 |
| LTPA2016041I1 (lt) | 2017-01-10 |
| CY1118543T1 (el) | 2017-06-28 |
| US20100008859A1 (en) | 2010-01-14 |
| LTC2330892I2 (lt) | 2018-06-11 |
| EP2330892B1 (en) | 2016-06-29 |
| CA2735218A1 (en) | 2009-11-05 |
| US20140256807A1 (en) | 2014-09-11 |
| EP2330892A1 (en) | 2011-06-15 |
| HUS1600057I1 (hu) | 2017-01-30 |
| GB201013468D0 (en) | 2010-09-22 |
| GB2470310A (en) | 2010-11-17 |
| DK2330892T3 (en) | 2016-08-22 |
| CY2016053I1 (el) | 2017-06-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL3133396T3 (pl) | Sposób leczenia z zastosowaniem leków wychwytujących amoniak | |
| PL2338519T3 (pl) | Środek do leczenia zwłóknienia szpiku | |
| BRPI0910854A2 (pt) | métodos de tratamento | |
| IT1391555B1 (it) | Apparato trattamento extracorporeo sangue | |
| PL3476371T3 (pl) | Urządzenie do leczenia gerd | |
| BRPI0910259A2 (pt) | métodos de tratamento de inflamação | |
| EP2373163A4 (en) | Heterocyclic compounds and methods of use | |
| PL3181134T3 (pl) | Bifidobakterie do leczenia cukrzycy i stanów pokrewnych | |
| BRPI0914294A2 (pt) | aparelho de tratamento de cápsulas | |
| BRPI0921321A2 (pt) | métodos para o tratamento de indwcções e tumores | |
| SMAP200900085A (it) | 3-imidazolil-indoli per il trattamento di malattieproliferative | |
| BRPI0917575A2 (pt) | métodos de tratamento de talassemia | |
| DK2330887T3 (da) | Behandlingsindretning | |
| BR112012022879A2 (pt) | composto, composição farmacêutica, uso do composto e método de tratamento | |
| HUE045367T2 (hu) | Kombinált terápia diabétesz kezelésére | |
| BRPI0915822A2 (pt) | dispositivo médico | |
| PL2582366T3 (pl) | Kombinacja farmaceutyczna do leczenia bólu | |
| DK2173831T3 (da) | Brøndbehandling | |
| EP3381471C0 (en) | PAIN TREATMENT | |
| ZA201006827B (en) | Carboxamide-heteroaryl derivatives for the treatment of diabetes | |
| DK3150178T3 (da) | Stimuleringsapparat | |
| DK2265296T3 (da) | Medicinske apparater med hydrofile belægninger | |
| HRP20181877T1 (hr) | Postupci za liječenje lijekovima koji uklanjaju amonijak | |
| EP2393836A4 (en) | SAM-6 VARIANTS, TARGET AND METHODS OF USING SAME | |
| BRPI0822129A2 (pt) | Inibidores de aldh-2c no tratamento de vício. |